Axoft’s Fleuron™ material is up to 10,000x softer than the polyimide used in existing brain implant devices and has been used in an in-human study at The Panama Clinic. Many iBCIs struggle to maintain ...
With the completion of a $55m fundraise, Axoft is planning to advance the development of its implantable brain-computer interfaces (iBCI). The Massachusetts-based company's oversubscribed Series A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results